Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
14
Number of overlapping holdings
28.0%
% of FTXH's 51 holdings also in XPH
35.0%
% of XPH's 40 holdings also in FTXH
Overlap by Weight
Sector Drift (FTXH minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
MERCK & CO. INC. | 7.4% | 4.8% | 4.8% |
|
PFIZER INC | 7.3% | 4.6% | 4.6% |
|
JOHNSON & JOHNSON | 6.9% | 4.5% | 4.5% |
|
BRISTOL-MYERS SQUIBB CO | 7.4% | 4.4% | 4.4% |
|
ELI LILLY & CO | 3.8% | 4.8% | 3.8% |
Position Highlights (Non-Overlapping Exposures)
FTXH Overweight Relative to XPH
|
ABBVIE INC | 7.1% |
|
AMGEN INC | 3.6% |
|
CARDINAL HEALTH INC | 3.6% |
|
REGENERON PHARMACEUTICALS | 3.6% |
|
VERTEX PHARMACEUTICALS INC | 3.5% |
|
GILEAD SCIENCES INC | 3.5% |
|
BIOGEN IDEC INC | 3.4% |
|
UNITED THERAPEUTICS CORP | 3.4% |
|
BRISTOL-MYERS SQUIBB CO | 2.9% |
|
PFIZER INC | 2.8% |
FTXH Underweight Relative to XPH
|
CATALENT INC | -4.7% |
|
AXSOME THERAPEUTICS, INC. | -4.6% |
|
ROYALTY PHARMA PLC CLASS A | -4.5% |
|
INTRA-CELLULAR THERAPIES INC | -4.2% |
|
ELANCO ANIMAL HEALTH, INC. | -3.6% |
|
CORCEPT THERAPEUTICS INC | -3.6% |
 |
PERRIGO CO | -3.3% |
|
ARVINAS, INC. | -2.4% |
|
PSIVIDA CORP | -2.2% |
|
AMPHASTAR PHARMACEUTICALS INC | -2.1% |